PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, featuring promising improvements across a variety of healthcare and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA supplies a safer, more trusted different for therapeutic use, specia